Literature DB >> 17952396

The complex pathways of Wnt 5a in cancer progression.

Tobias Pukrop1, Claudia Binder.   

Abstract

In contrast to the transforming members of the Wnt family, shown to be upregulated in many cancers, the role of Wnt 5a is still controversial. While it has been attributed a tumour suppressor function in some malignancies, there is increasing evidence of promigratory and proinvasive effects in others, mediated predominantly through the planar cell polarity pathway and activation of protein kinase C. Obviously, the outcome of an individual Wnt 5a signal is dependent on a multitude of variables, ranging from availability of receptors, downstream effectors, and inhibitors to external influences coming from the tumour microenvironment and the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952396     DOI: 10.1007/s00109-007-0266-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  76 in total

Review 1.  Tales from the crypt[ic] sites of the extracellular matrix.

Authors:  Susann Schenk; Vito Quaranta
Journal:  Trends Cell Biol       Date:  2003-07       Impact factor: 20.808

Review 2.  Altered Rho GTPase signaling pathways in breast cancer cells.

Authors:  Peter Burbelo; Anton Wellstein; Richard G Pestell
Journal:  Breast Cancer Res Treat       Date:  2004-03       Impact factor: 4.872

3.  Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.

Authors:  Manabu Kurayoshi; Hideki Yamamoto; Shunsuke Izumi; Akira Kikuchi
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

4.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

Review 5.  Clinical, cellular, and molecular aspects of cancer invasion.

Authors:  Marc Mareel; Ancy Leroy
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

Review 6.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

7.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 9.  TNF-alpha in promotion and progression of cancer.

Authors:  Frances Balkwill
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

10.  Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.

Authors:  Michiru Nishita; Sa Kan Yoo; Akira Nomachi; Shuichi Kani; Nagako Sougawa; Yasutaka Ohta; Shinji Takada; Akira Kikuchi; Yasuhiro Minami
Journal:  J Cell Biol       Date:  2006-11-13       Impact factor: 10.539

View more
  31 in total

1.  Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.

Authors:  Benjamin G Bitler; Jasmine P Nicodemus; Hua Li; Qi Cai; Hong Wu; Xiang Hua; Tianyu Li; Michael J Birrer; Andrew K Godwin; Paul Cairns; Rugang Zhang
Journal:  Cancer Res       Date:  2011-08-04       Impact factor: 12.701

2.  Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling.

Authors:  Kushagra Bansal; Jamma Trinath; Dipshikha Chakravortty; Shripad A Patil; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

3.  The roles of Wnt5a, JNK and paxillin in the occurrence of metastasis of pancreatic adenocarcinoma.

Authors:  Wenli Lu; Wei Wei; Geertruida H de Bock; Hongyuan Zhou; Qiang Li; Xiaohong Shen
Journal:  Int J Clin Oncol       Date:  2013-12-25       Impact factor: 3.402

4.  Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.

Authors:  Fatma Trifa; Sondes Karray-Chouayekh; Emna Jmal; Zeineb Ben Jmaa; Abdelmajid Khabir; Tahia Sellami-Boudawara; Mounir Frikha; Jamel Daoud; Raja Mokdad-Gargouri
Journal:  Tumour Biol       Date:  2013-02-16

5.  Microglia-induced activation of non-canonical Wnt signaling aggravates neurodegeneration in demyelinating disorders.

Authors:  Takeshi Shimizu; Ron Smits; Kazuhiro Ikenaka
Journal:  Mol Cell Biol       Date:  2016-08-22       Impact factor: 4.272

6.  Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer.

Authors:  Sayuri Takahashi; Tomoyuki Watanabe; Maiko Okada; Kazuki Inoue; Takashi Ueda; Ichiro Takada; Tetsuro Watabe; Yoko Yamamoto; Toru Fukuda; Takashi Nakamura; Chihiro Akimoto; Tetsuya Fujimura; Maiko Hoshino; Yuuki Imai; Daniel Metzger; Kohei Miyazono; Yasuhiro Minami; Pierre Chambon; Tadaichi Kitamura; Takahiro Matsumoto; Shigeaki Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

7.  Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

Authors:  Mark A Gregory; Tzu L Phang; Paolo Neviani; Francesca Alvarez-Calderon; Christopher A Eide; Thomas O'Hare; Vadym Zaberezhnyy; Richard T Williams; Brian J Druker; Danilo Perrotti; James Degregori
Journal:  Cancer Cell       Date:  2010-07-13       Impact factor: 31.743

8.  WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors.

Authors:  Waleerat Sukarawan; Darrin Simmons; Cynthia Suggs; Kimberly Long; J Timothy Wright
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

9.  Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple.

Authors:  Nicolas Aznar; Jason Ear; Ying Dunkel; Nina Sun; Kendall Satterfield; Fang He; Nicholas A Kalogriopoulos; Inmaculada Lopez-Sanchez; Majid Ghassemian; Debashis Sahoo; Irina Kufareva; Pradipta Ghosh
Journal:  Sci Signal       Date:  2018-02-27       Impact factor: 8.192

10.  Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.

Authors:  Anna Spreafico; John J Tentler; Todd M Pitts; Aik Choon Tan; Mark A Gregory; John J Arcaroli; Peter J Klauck; Martine C McManus; Ryan J Hansen; Jihye Kim; Lindsey N Micel; Heather M Selby; Timothy P Newton; Kelly L McPhillips; Daniel L Gustafson; James V Degregori; Wells A Messersmith; Robert A Winn; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2013-06-11       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.